Cargando…
High levels of multiresistance in quinolone resistant urinary tract isolates of Escherichia coli from Norway; a non clonal phenomen?
BACKGROUND: The problem of emerging ciprofloxacin resistance is compounded by its frequent association with multiresistance, the reason for which is not fully understood. In this study we compare multiresistance, clonal similarities and phylogenetic group in urinary tract isolates of Escherichia col...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077835/ https://www.ncbi.nlm.nih.gov/pubmed/24941949 http://dx.doi.org/10.1186/1756-0500-7-376 |
_version_ | 1782323662933721088 |
---|---|
author | Strand, Linda Jenkins, Andrew Henriksen, Ingrid Høgli Allum, Anne Gry Grude, Nils Kristiansen, Bjørn Erik |
author_facet | Strand, Linda Jenkins, Andrew Henriksen, Ingrid Høgli Allum, Anne Gry Grude, Nils Kristiansen, Bjørn Erik |
author_sort | Strand, Linda |
collection | PubMed |
description | BACKGROUND: The problem of emerging ciprofloxacin resistance is compounded by its frequent association with multiresistance, the reason for which is not fully understood. In this study we compare multiresistance, clonal similarities and phylogenetic group in urinary tract isolates of Escherichia coli sensitive and resistant to the quinolone antimicrobials nalidixic acid and ciprofloxacin. RESULTS: Quinolone resistant isolates were more resistant to non-quinolone antibiotics than sensitive isolates, with resistance to ampicillin, mecillinam, sulphonamide, trimethoprim, tetracycline, kanamycin and chloramphenicol significantly increased. Fifty-one percent of quinolone-resistant isolates were multiresistant. Although multiresistance was most prevalent (63%) in isolates showing high-level ciprofloxacin resistance, it was still highly prevalent (41%) in nalidixic acid resistant isolates with low-level ciprofloxacin resistance. Multiresistance was more frequent among singleton isolates (61%) than clonal isolates (40%) of quinolone resistant Escherichia coli. Ciprofloxacin resistance was associated with certain specific clones, among them the globally distributed clonal Group A. However, there was no significant difference in the overall degree of clonality between quinolone sensitive and resistant isolates. Ciprofloxacin resistance was positively associated with phylogroup D and negatively associated with phylogroup B2. This correlation was not associated with clonal isolates. CONCLUSION: This study supports earlier findings of association between ciprofloxacin resistance and resistance to other antibiotics. The prevalence of multiresistance in quinolone-resistant isolates that have not yet developed high-level ciprofloxacin resistance suggest that multiresistance arises early in the development of quinolone resistance. This is consistent with exposure to quinolones causing quinolone resistance by mutations and mobilization of multiresistance elements by induction of the SOS response. The spread of clones seems to be less important than previously reported in regard to emergence of quinolone resistance and multiresistance as both are associated primarily with singleton isolates. |
format | Online Article Text |
id | pubmed-4077835 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40778352014-07-02 High levels of multiresistance in quinolone resistant urinary tract isolates of Escherichia coli from Norway; a non clonal phenomen? Strand, Linda Jenkins, Andrew Henriksen, Ingrid Høgli Allum, Anne Gry Grude, Nils Kristiansen, Bjørn Erik BMC Res Notes Research Article BACKGROUND: The problem of emerging ciprofloxacin resistance is compounded by its frequent association with multiresistance, the reason for which is not fully understood. In this study we compare multiresistance, clonal similarities and phylogenetic group in urinary tract isolates of Escherichia coli sensitive and resistant to the quinolone antimicrobials nalidixic acid and ciprofloxacin. RESULTS: Quinolone resistant isolates were more resistant to non-quinolone antibiotics than sensitive isolates, with resistance to ampicillin, mecillinam, sulphonamide, trimethoprim, tetracycline, kanamycin and chloramphenicol significantly increased. Fifty-one percent of quinolone-resistant isolates were multiresistant. Although multiresistance was most prevalent (63%) in isolates showing high-level ciprofloxacin resistance, it was still highly prevalent (41%) in nalidixic acid resistant isolates with low-level ciprofloxacin resistance. Multiresistance was more frequent among singleton isolates (61%) than clonal isolates (40%) of quinolone resistant Escherichia coli. Ciprofloxacin resistance was associated with certain specific clones, among them the globally distributed clonal Group A. However, there was no significant difference in the overall degree of clonality between quinolone sensitive and resistant isolates. Ciprofloxacin resistance was positively associated with phylogroup D and negatively associated with phylogroup B2. This correlation was not associated with clonal isolates. CONCLUSION: This study supports earlier findings of association between ciprofloxacin resistance and resistance to other antibiotics. The prevalence of multiresistance in quinolone-resistant isolates that have not yet developed high-level ciprofloxacin resistance suggest that multiresistance arises early in the development of quinolone resistance. This is consistent with exposure to quinolones causing quinolone resistance by mutations and mobilization of multiresistance elements by induction of the SOS response. The spread of clones seems to be less important than previously reported in regard to emergence of quinolone resistance and multiresistance as both are associated primarily with singleton isolates. BioMed Central 2014-06-19 /pmc/articles/PMC4077835/ /pubmed/24941949 http://dx.doi.org/10.1186/1756-0500-7-376 Text en Copyright © 2014 Strand et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Strand, Linda Jenkins, Andrew Henriksen, Ingrid Høgli Allum, Anne Gry Grude, Nils Kristiansen, Bjørn Erik High levels of multiresistance in quinolone resistant urinary tract isolates of Escherichia coli from Norway; a non clonal phenomen? |
title | High levels of multiresistance in quinolone resistant urinary tract isolates of Escherichia coli from Norway; a non clonal phenomen? |
title_full | High levels of multiresistance in quinolone resistant urinary tract isolates of Escherichia coli from Norway; a non clonal phenomen? |
title_fullStr | High levels of multiresistance in quinolone resistant urinary tract isolates of Escherichia coli from Norway; a non clonal phenomen? |
title_full_unstemmed | High levels of multiresistance in quinolone resistant urinary tract isolates of Escherichia coli from Norway; a non clonal phenomen? |
title_short | High levels of multiresistance in quinolone resistant urinary tract isolates of Escherichia coli from Norway; a non clonal phenomen? |
title_sort | high levels of multiresistance in quinolone resistant urinary tract isolates of escherichia coli from norway; a non clonal phenomen? |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077835/ https://www.ncbi.nlm.nih.gov/pubmed/24941949 http://dx.doi.org/10.1186/1756-0500-7-376 |
work_keys_str_mv | AT strandlinda highlevelsofmultiresistanceinquinoloneresistanturinarytractisolatesofescherichiacolifromnorwayanonclonalphenomen AT jenkinsandrew highlevelsofmultiresistanceinquinoloneresistanturinarytractisolatesofescherichiacolifromnorwayanonclonalphenomen AT henrikseningridhøgli highlevelsofmultiresistanceinquinoloneresistanturinarytractisolatesofescherichiacolifromnorwayanonclonalphenomen AT allumannegry highlevelsofmultiresistanceinquinoloneresistanturinarytractisolatesofescherichiacolifromnorwayanonclonalphenomen AT grudenils highlevelsofmultiresistanceinquinoloneresistanturinarytractisolatesofescherichiacolifromnorwayanonclonalphenomen AT kristiansenbjørnerik highlevelsofmultiresistanceinquinoloneresistanturinarytractisolatesofescherichiacolifromnorwayanonclonalphenomen |